Efficacy and safety of sofosbuvir plus ribavirin for Korean patients with hepatitis C virus genotype 2 infection: A retrospective multi-institutional study

BACKGROUND/AIMS: Sofosbuvir plus ribavirin is a standard treatment for patients infected with chronic hepatitis C virus (HCV) genotype 2 in Korea. The purpose of this study was to examine the efficacy and safety of this treatment in Korean patients with chronic HCV genotype 2 infection. METHODS: We...

Descripción completa

Detalles Bibliográficos
Autores principales: Kim, Young Min, Kim, Suk Bae, Song, Il Han, Lee, Sae Hwan, Kim, Hong Soo, Lee, Tae Hee, Kang, Young Woo, Kim, Seok Hyun, Lee, Byung Seok, Chae, Hee Bok, Song, Myeong Jun, Jang, Ji Woong, Ko, Soon Young, Lee, Jae Dong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Korean Association for the Study of the Liver 2018
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6166109/
https://www.ncbi.nlm.nih.gov/pubmed/29865774
http://dx.doi.org/10.3350/cmh.2017.0070

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6166109/
https://www.ncbi.nlm.nih.gov/pubmed/29865774
http://dx.doi.org/10.3350/cmh.2017.0070

Ejemplares similares